evidence based solutions

Products & Pipeline

Anatara Lifesciences is developing and commercialising innovative, evidence-based health products to address significant unmet need, with a particular focus on conditions that involve the complexity of the gastrointestinal tract.

Gastrointestinal ReProgramming
(GaRP) Product

Introducing GaRP as a multicomponent, multicoated complementary medicine for IBS and other indications.

Anti-Obesity Program

Anatara Lifesciences is developing an oral product aimed at supporting weight reduction and sustainable weight management.

Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) is the most commonly diagnosed gastrointestinal condition and a significant cost burden on health care.

Animal
Applications

Anatara is developing Non-antibiotic products for pigs and poultry.

Partnering Opportunities

Anatara is seeking to partner with international pharmaceutical and consumer health companies for the commercialisation of its products.
Evidence-based treatments for gastrointestinal health
About Us
Products
Investments
News & Media
Contact Us
Want to stay up to date with our trials and latest news?
Sign up here

    All rights reserved © Anatara Lifesciences 2024